This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination status may help reopen airports and other badly hit areas of the economy, reports Richard Staines. But getting the technology to work is taking time.
. “Some of these drugs are studies that traditionally get offered to cardiologists in hospitals, and actually, when you look at the protocols, they are not the best place to run those trials,” she explained. Eloise McLennan is the editor for pharmaphorum’s Deep Dive magazine. moderator).
Clinical trials are slower to run and complete because hospitals are busy with COVID-19 cases. It has brought a lot of good things working together and networking has led to unbelievable successes,” he added, noting the rapid development of vaccines by companies such as Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University.
This alone causes expense for cash-strapped hospitals and puts pressure on nursing and medical staff while they manage the side effects. “These are patients who are extremely sick and the thought of a therapy involving multiple visits to hospital for injections and invasive procedures may not appeal.
Jaguar Gene Therapy is building a $125 million facility in RTP to manufacture adeno-associated virus (AAV)-based gene therapies, Beam Therapeutics is constructing an $83 million plant to develop precision medicines, and IQVIA, a CRO, opened an innovation lab in the park in 2021, focusing on bioanalytics, vaccines, biomarkers, and genomics.
She ranked 2nd on the “Most Powerful International Women” of Fortune Magazine 2019 edition Education: She holds a master’s degree in classics and modern languages from Oxford University Other Affiliations: Emma was appointed as Independent Director for Microsoft board in Dec’19. LinkedIn Total experience: 31 yrs.
T-Mobile went into partnership with Verizon, AT&T, and iHeartMedia to give 40,000 phone chargers to hospitals, putting frightened, isolated patients back in touch with loved ones. Pfizer has four different mRNA platform vaccines in play against one-another: a radical new approach for them. Verizon also donated $2.5
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content